Veru Inc. NASDAQ Capital Market
Open: $16.2 High: $16.7 Low: $16.04 Close: $16.2
Range: 2022-05-18 - 2022-05-19
Market: Extended-hours
Veru Inc. 2916 N. MIAMI AVENUE
Veru Inc is a biopharmaceutical company focused on urology and oncology. It develops prescription products for benign prostatic hyperplasia hot flashes associated with cancer treatment, male infertility, and novel chemotherapies for a variety of cancers. The company currently operates in two reporting segments: Sexual health business and Research & development. Some of its products include Zuclomiphene, Veru-111, Veru-100, FC2, and Roman Swipes. The company generates the majority of its revenue from the United States.
  • CEO: Mitchell S. Steiner
  • Employees: 252
  • Sector: Healthcare
  • Industry: Drug Manufacturers
Latest Stocks Posts
Card image
Card image
Card image
Latest news about the VERU